Onconova Therapeutics Inc... (ONTX)
NASDAQ: ONTX
· Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Apr 02, 2024, 8:00 PM
0.00% (1D)
| Bid | n/a |
| Market Cap | 20.9M |
| Revenue (ttm) | 226K |
| Net Income (ttm) | -18.16M |
| EPS (ttm) | -0.96 |
| PE Ratio (ttm) | -1.0367708333333332 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 1,254,618 |
| Avg. Volume (20D) | 126,338 |
| Open | 1.00 |
| Previous Close | 1.00 |
| Day's Range | 0.77 - 1.00 |
| 52-Week Range | 0.55 - 1.45 |
| Beta | 1.35 |
About ONTX
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with P...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 25, 2013
Employees 16
Stock Exchange NASDAQ
Ticker Symbol ONTX
Website https://www.onconova.com